207_Combined course Presentations

ACT I Phase III Trial Time to Disease by T Stage

CMT better RT better

CMT

RT

4/11 (36%)

(63%) 5/8

N/K

1.53

0.10

0.40

7/35 (20%)

(50%) 18/36

T1

0.16

0.92

0.38

26/84 (31%)

(53%) 53/100

T2

0.86

0.34

0.5 4

41/111 (37%)

(65%) 70/108

T3

0.72

0.33

0.49

25/43 (58%)

(83%) 24/29

T4

0.92

0.30

0.52

103/284 (36%)

(60%) 170/28

Combined

0.39

0.63

Stratified by T Stage

0.50

0 0.25 0.5 0.75 1 1.25 1.5